• Home
  • Stocks
  • Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals & Pharmaceuticals Ltd.

View in App
70.95 +5.55 ▲8.5%

16 April 2024, 11:30:53 AM
Volume: 43,302

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biofilgroup.net
Market Cap 109.93 Cr.
Enterprise Value(EV) 107.15 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.41 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 164.32 Trailing Twelve Months Ending 2023-12
Industry PE 40.96 Trailing Twelve Months Ending 2023-12
Book Value / Share 10.92 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.19 Calculated using Price: 67.55
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.63 Cr. 16,273,800 Shares
FaceValue 10
About Biofil Chemicals & Pharmaceuticals Ltd.
Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Biofil Chemicals & Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Biofil Chemicals & Pharmaceuticals Ltd. Performance

View details >>
1 Day
+8.49%
1 Week
+6.61%
1 Month
+17.18%
3 Month
+23.61%
6 Month
+40.08%
1 Year
+59.26%
2 Year
+10.69%
5 Year
+833.55%
10 Year

Biofil Chemicals & Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 13.47 13.28 18.09 3.64 3.6 8.46 8.01 4.24 3.28
Return on Capital Employed (%) 12.97 14.04 21.86 5.13 5.06 10.12 12.18 6.23 4.76
Return on Assets (%) 4.14 4.13 7.81 2.05 1.99 3.63 3.28 2.69 2.24

Biofil Chemicals & Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8 11 13 13 14 15 16 17 17 18
Non Curr. Liab. 0 0 0 0
Curr. Liab. 5 13 9 11 11 27 17 1 14 24
Minority Int.
Equity & Liab. 14 24 22 24 24 42 33 19 31 42
Non Curr. Assets 9 9 9 9 10 10 10 9 9 9
Curr. Assets 5 15 13 15 14 32 23 9 22 33
Misc. Exp. not W/O
Total Assets 14 24 22 24 24 42 33 19 31 42

Biofil Chemicals & Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 6 13 13 12 23 30 36 22 30 38
Other Income 0 1 0 0 0 0 1 0 0 0
Total Income 6 14 14 12 23 30 37 23 30 39
Total Expenditure -5 -12 -11 -11 -22 -28 -34 -21 -29 -37
PBIDT 1 1 3 1 1 2 2 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 -1 0 0 0 -1 0 0 0
Exceptional Items
PAT 1 1 2 0 0 1 1 1 1 1
Adjusted EPS 0 0 1 0 0 1 1 0 0 0

Biofil Chemicals & Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 0 1 1 1 0 0
Cash Fr. Inv. 0 0 0 0 0 -1 0 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 -1 -1 0 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Biofil Chemicals & Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 46.82 46.82 46.82 46.82 46.82 46.82 46.82 46.82 46.82
Public 53.18 53.18 53.18 53.18 53.18 53.18 53.18 53.18 53.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Biofil Chemicals & Pharmaceuticals Ltd. Announcements

View details >>
Tue, 09 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation
Tue, 09 Apr 2024
Loss of Share Certificates
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates
Wed, 03 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Biofil Chemicals & Pharmaceuticals Ltd. Technical Scans

View details >>
Mon, 15 Apr 2024
Higher Trade Quantity Higher Trade Quantity
Closing Below Previous Low Closing Below Previous Low
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Biofil Chemicals & Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,773.51 1,531.35 -0.6%
Cipla Ltd. 111,517.58 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. 100,257.78 6,059.65 +0.8%
Divi's Laboratories Ltd. 98,636.18 3,730.10 +0.4%
Zydus Lifesciences Ltd. 94,082.88 953.45 +2.0%
Mankind Pharma Ltd. 90,721.26 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. 90,631.78 6,226.45 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.52 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-12 30.07 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.18 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-12 71.32 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.64 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-12 52.53 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 114.82 6,226.45 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.93 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-12 4.31 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.99 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.21 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.42 6,226.45 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,226.45 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,226.45 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,226.45 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,226.45 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,531.35 -0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,389.45 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,059.65 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,730.10 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 953.45 +2.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,276.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,226.45 -1.2%

Biofil Chemicals & Pharmaceuticals Ltd. FAQ's

What is Biofil Chem & Pharma share price?
Can I buy Biofil Chem & Pharma shares now?
What is the Market Cap of Biofil Chem & Pharma?
What are the key metrics to analyse Biofil Chem & Pharma?
What is the 52 Week High and Low of Biofil Chem & Pharma?
What is the trend of Biofil Chem & Pharma share price?